Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
letter
. 1984 Sep;76(9):887–896.

Sarcoidosis—The Beginning: Historical Highlights of Personalities and Their Accomplishments During the Early Years

Roscoe C Young Jr, Raylinda E Rachal, Claude L Cowan Jr
PMCID: PMC2561666  PMID: 6387158

Abstract

Sarcoidosis, an affliction of mankind named only as recently as this century, was first described by Hutchinson in 1878, and noted in a second patient, one Mrs. Mortimer, in 1898. In 1889, Besnier described lupus pernio.

Boeck obtained skin biopsies in 1899. Kreibich described punched-out bone lesions in 1904. Darier and Roussy described subcutaneous nodules in 1906, and Heerfordt described uveoparotid fever in 1909. Schaumann synthesized the many diverse syndromes of sarcoidosis into a single disease in a prizewinning essay in 1914. Kveim biopsied the sarcoid skin test-site and established a diagnostic test in 1941.

Lofgren described the bilateral hilar lymphadenopathy-erythema nodosum syndrome in 1946. In 1954, Israel and Sones helped establish sarcoidosis as an immunologic disorder. In 1963 Cummings compiled a bibliography on sarcoidosis, and in 1966 Siltzbach conducted his renowned international Kveim test trial.

At Howard University, Harden ignited an interest in sarcoidosis. In 1944 Johnson and Jason contributed to a description of cardiac involvement, while Cowan studied ocular involvement in sarcoidosis.

Full text

PDF
891

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHASE M. W. The preparation and standardization of Kveim testing antigen. Am Rev Respir Dis. 1961 Nov;84(5):86–88. doi: 10.1164/arrd.1961.84.5P2.86. [DOI] [PubMed] [Google Scholar]
  2. FRIOU G. J. A study of the cutaneous reactions to oidiomycin, trichophytin, and mumps skin test antigens in patients with sarcoidosis. Yale J Biol Med. 1952 Jun;24(6):533–539. [PMC free article] [PubMed] [Google Scholar]
  3. HARDEN K. A., BARTHAKUR A., CARR C. Sarcoidosis; a functional classification. Med Ann Dist Columbia. 1959 Mar;28(3):129–133. [PubMed] [Google Scholar]
  4. HARDEN K. A., BARTHAKUR A. Cavitary lesions in sarcoidosis. Dis Chest. 1959 Jun;35(6):607–614. doi: 10.1378/chest.35.6.607. [DOI] [PubMed] [Google Scholar]
  5. Israel H. L., Park C. H., Mansfield C. M. Gallium scanning in sarcoidosis. Ann N Y Acad Sci. 1976;278:514–516. doi: 10.1111/j.1749-6632.1976.tb47063.x. [DOI] [PubMed] [Google Scholar]
  6. LOFGREN S. Primary pulmonary sarcoidosis. I. Early signs and symptoms. Acta Med Scand. 1953;145(6):424–431. [PubMed] [Google Scholar]
  7. SILTZBACH L. E. Current status of the Nickerson-Kveim reaction. Am Rev Respir Dis. 1961 Nov;84(5):89–93. doi: 10.1164/arrd.1961.84.5P2.89. [DOI] [PubMed] [Google Scholar]
  8. SILTZBACH L. E. Pulmonary sarcoidosis. Am J Surg. 1955 Feb;89(2):556–568. doi: 10.1016/0002-9610(55)90100-8. [DOI] [PubMed] [Google Scholar]
  9. SONES M., ISRAEL H. L. Altered immunologic reactions in sarcoidosis. Ann Intern Med. 1954 Feb;40(2):260–268. doi: 10.7326/0003-4819-40-2-260. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES